Onconova Therapeutics (ONTX) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.31
-0.27
-0.24
-0.2

Details

Expected EPS
-0.31
Actual EPS
-0.2
Surprise EPS
0.11
Surprise Percent
+35.48%

Description

Onconova Therapeutics (ONTX) has reported earnings of -0.2 per share for Q2 2023.

0 Comments

Share your thoughts